A Single Dose Study of SHR0410 in Healthy Male Participants
Status:
Completed
Trial end date:
2018-07-14
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, single ascending-dose study to
investigate the effect of a single intravenous (IV) dose of SHR0410 at 6 dose levels (0.5
μg/kg, 1 μg/kg, 2 μg/kg, 5 μg/kg, 10 μg/kg and 20 μg/kg) in healthy participants.